References
- Tonnerre P, Delmotte H. Undesirable effects of AIDS treatment. Rev Infirm 2003;94:12–5.
- Podzamczer D, Consiglio E, Ferrer E, Gudio F. Efavirenz associated with corticosteroids in patients with previous severe hypersensitivity reaction due to nevirapine. AIDS 2000;14:331–2.
- US Public Health Service. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001; 50(RR-11):1–52.
- Bossi P, Colin D, Bricaire F, Caumes E. Hypersensitivity syndrome associated with efavirenz therapy. Clin Infect Dis 2000;30:227–8.
- Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, . Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 1999;341: 1865–73.
- Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, Brundage RC, . Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med 1999;341:1874–81.
- Newell A, Avila C, Radgers ME. Photosensitivity reaction of efavirenz. Sex Transm Infect 2000;76:221.
- Treudler R, Husak R, Raisova M, Orfanos CE, Tebbe B. Efavirenz induced photoallergic dermatitis in HIV. AIDS 2001;15:1085–6.
- Yoshimoto E, Konishi M, Takahashi K, Murakawa K, Maeda K, Mikasa K, . The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection. Intern Med 2004;43:630–1.